Diaverum is a prominent multinational healthcare organization focused on providing comprehensive renal care to patients with Chronic Kidney Disease (CKD). Founded in 1991 and headquartered in Sweden, the company has a strong presence in the industry, caring for approximately 40,000 patients across 450 clinics in 24 countries worldwide. The company's offerings span from preventive treatments to the coordination of transplantation services, ensuring a patient-centric approach to care. Diaverum's commitment to innovation is evident through their vision of transforming the industry with digital solutions to broaden access to high-quality renal care. The company received a Private Equity Round investment in January 2007 from the Canada Pension Plan Investment Board, further cementing its position as a leader in the Health Care sector.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Private Equity Round | Unknown | 1 | Canada Pension Plan Investment Board | 01 Jan 2007 |
No recent news or press coverage available for Diaverum.